Healthcare -
Biotechnology - NASDAQ - US
$ 8.115
1.06 %
$ 631 M
Market Cap
-3.45
P/E
KURA - STOCK-BASED COMPENSATION
Stock-based Compensation KURA - Kura Oncology, Inc.
28.1 M
LAST VALUE
9.13%
2 YEAR CAGR
26.54%
5 YEAR CAGR
0.00%
10 YEAR CAGR